Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $0.06 USD
Change Today -0.0016 / -2.62%
Volume 560.6K
ISCO On Other Exchanges
Symbol
Exchange
OTC US
Berlin
As of 10:16 AM 03/30/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Ruslan Semechkine Ph.D.

Chief Scientific Officer and Director, International Stem Cell Corporation
AgeTotal Calculated CompensationThis person is connected to 12 board members in 1 different organizations across 1 different industries.

See Board Relationships
29$325,470
As of Fiscal Year 2014

Background*

Dr. Ruslan Semechkine, Ph.D., has been Chief Scientific Officer of International Stem Cell Corporation., since June 2013. Dr. Semechkine has been President of X-Master, Inc. since May 2006. Dr. Semechkine has both scientific expertise and international relationships. Dr. Semechkine served as Vice President of International Stem Cell Corporation. He served as the Chief Executive Officer of Lifeline Skin Care a subsidiary of International Stem Cell Corporation. Dr. Semechkine ...

Read Full Background

Corporate Headquarters*

5950 Priestly Drive
Carlsbad, California 92008

United States

Phone: 760-940-6383
Fax: 760-476-0600

Board Members Memberships*

2008-Present
Chief Scientific Officer and Director

Education*

MS
Lomonosov Moscow State University
Honors Degree
Lomonosov Moscow State University
PhD
Russian Academy of Medical Sciences

Other Affiliations*

Annual Compensation*

Salary$196,923
Total Annual Compensation$196,923

Stock Options*

Unexercisable Options914,167
Total Number of Options2,105,000

Total Compensation*

Total Annual Cash Compensation$196,923
Total Short Term Compensation$196,923
Total Calculated Compensation$325,470
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ISCO:US $0.06 USD -0.0016

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Olav Hellebo Chief Executive Officer
ReNeuron Group plc
--
Marc H. Hedrick M.D.Chief Executive Officer, President, Director and Member of Executive Committee
Cytori Therapeutics, Inc.
$437.4K
Martin M. McGlynn Chief Executive Officer, Chief Executive Officer of Stemcells California Inc, President of Stemcells California Inc, Director and Member of Strategic Transactions Committee
StemCells Inc.
$835.8K
Martin P. Rosendale Chief Executive Officer and Director
Nuo Therapeutics, Inc.
$467.3K
Mike Tomas Chief Executive Officer, President, Chief Financial Officer, Director and Member of Advisory Board
Bioheart, Inc.
$766.7K
Compensation as of Fiscal Year --.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact INTERNATIONAL STEM CELL CORP, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.